Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 3-Hydroxy-2-(hydroxymethyl)-4-[N-[(3-methylphenyl)methyl]-C-pentadecylcarbonimidoyl]-2H-furan-5-one | IC50 | 1600.0 [1], 1630.0 [2], 100000.0 [3] | |
| (5R)-3-Hexadecanoyl-4-hydroxy-5-(hydroxymethyl)furan-2(5H)-one | IC50 | 10200.0 [1], 11700.0 [2] | |
| 2-[(5Z)-5-[[3-[4-[(2-Fluorophenyl)methoxy]phenyl]-1-phenylpyrazol-4-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]ethanesulfonic acid | IC50 | 74.0 [1] | |
| 5-[2-(4-Ethoxyphenyl)-1,3-thiazol-4-yl]-2,3-dihydro-1H-1,3-benzodiazol-2-one | IC50 | 1900.0 [1], 20100.0 [2] | |
| 1-Methanesulfonyl-5-[2-(3-methylphenyl)-1,3-thiazol-4-yl]-2,3-dihydro-1H-indole | IC50 | 8000.0 [1], 40100.0 [2] | |
MLA | "Quest Database™ Dual specificity protein phosphatase 3 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 6 Dec. 2025, https://www.aatbio.com/data-sets/dual-specificity-protein-phosphatase-3-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 6). Quest Database™ Dual specificity protein phosphatase 3 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/dual-specificity-protein-phosphatase-3-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |